🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
296 million people worldwide are infected with the hepatitis B virus (HBV),...
Status
Recruiting
Location
Hôpital Saint Louis AP-HP
Start Date
2025-08-11
Trial ID
NCT06876467
Treatments Being Tested
Scares data exists concerning the prevalence of chronic liver diseases in p...
Status
Completed
Location
Montpellier University Hospital
Start Date
2023-03-07
Trial ID
NCT05602870
Treatments Being Tested
This study will assess HBV (HBsAg, anti-HBc and anti-HBs) prevalence in the...
Status
Unknown
Location
Ziekenhuis Oost-Limburg
Start Date
2017-09-01
Trial ID
NCT03396458
Treatments Being Tested
Regardless of its etiology (chronic hepatitis B or C, alcohol consumption, ...
Status
Recruiting
Location
Avicenne Hospital
Start Date
2025-06-19
Trial ID
NCT06755632
Treatments Being Tested
The aging of skin, especially that of the scalp, is a combination of intrin...
Status
Terminated
Location
Chu de Saint Etienne
Start Date
2019-02-14
Trial ID
NCT03603587
Immunisation policies have strong influences on the epidemiology of hepatit...
Status
Completed
Location
Prince of Wales Hospital
Start Date
2018-09-01
Trial ID
NCT04371276
Treatments Being Tested
The purpose of this clinical study is to evaluate the safety and the effica...
Status
Recruiting
Location
Emek Medical Center
Start Date
2017-07-27
Trial ID
NCT03024008
Treatments Being Tested
Achieving clinical cure, defined as hepatitis B surface antigen (HBsAg) ser...
Status
Recruiting
Location
Peking University People's Hospital
Start Date
2026-01-01
Trial ID
NCT07328711
Treatments Being Tested
Migrants' overall health status may be improved by increasing the detection...
Status
Completed
Location
Servicio Andaluz de Salud (SAS) (administration of the participant PCCs in Andalusia)
Start Date
2024-01-01
Trial ID
NCT05868005
This study will evaluate the persistence of the immune response to HAV (hep...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-01-27
Trial ID
NCT01037114
Treatments Being Tested